Fatty acids promote the expansion of NK-92 cells in vitro by improving energy metabolism

[21] Basaraba R(2020)Mitochondrial biogenesis: an update J Cell Mol Med 24 4892-19365

[22] van Crevel R(2020)Nicorandil affects mitochondrial respiratory chain function by increasing complex III activity and ROS production in skeletal muscle mitochondria J Membrane Boil 253 309-undefined

[23] Newell E(2019)Systems biology approach in the formulation of chemically defined media for recombinant protein overproduction Appl Microbiol Biotechnol 103 8315-undefined

[24] Kornfeld H(2018)Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives Oncotarget 9 20891-undefined

[25] Singhal A(2013)Treatment of patients with advanced cancer with the natural killer cell line NK-92 Cytotherapy 15 1563-undefined

[26] Bosch M(2019)NK cells: an attractive candidate for cancer therapy J Cell Physiol 234 19352-undefined

[27] Sanchez-Alvarez M(2020)Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions Front Immunol 11 202-undefined

[28] Fajardo A(2019)Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy J Immunother Cancer 7 138-undefined

[29] Kapetanovic R(undefined)undefined undefined undefined undefined-undefined

[30] Steiner B(undefined)undefined undefined undefined undefined-undefined

[21] Basaraba R(2020)Mitochondrial biogenesis: an update J Cell Mol Med 24 4892-19365

[22] van Crevel R(2020)Nicorandil affects mitochondrial respiratory chain function by increasing complex III activity and ROS production in skeletal muscle mitochondria J Membrane Boil 253 309-undefined

[23] Newell E(2019)Systems biology approach in the formulation of chemically defined media for recombinant protein overproduction Appl Microbiol Biotechnol 103 8315-undefined

[24] Kornfeld H(2018)Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives Oncotarget 9 20891-undefined

[25] Singhal A(2013)Treatment of patients with advanced cancer with the natural killer cell line NK-92 Cytotherapy 15 1563-undefined

[26] Bosch M(2019)NK cells: an attractive candidate for cancer therapy J Cell Physiol 234 19352-undefined

[27] Sanchez-Alvarez M(2020)Glycolysis and oxidative phosphorylation play critical roles in natural killer cell receptor-mediated natural killer cell functions Front Immunol 11 202-undefined

[28] Fajardo A(2019)Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy J Immunother Cancer 7 138-undefined

[29] Kapetanovic R(undefined)undefined undefined undefined undefined-undefined

[30] Steiner B(undefined)undefined undefined undefined undefined-undefined